Laurent Pharmaceuticals

About:

Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical stage, orally-active drug candidate.

Website: http://www.laurentpharma.com/

Top Investors: Keiretsu Capital, AQC Capital, Anges Quebec, Cystic Fibrosis Foundation, RSJ Investments SICAV a.s.

Description:

Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical-stage, orally-active drug candidate. The company has a clinical-stage drug development program (LAU-7b) that addresses the compromised immune-inflammatory response in Cystic Fibrosis (CF), a critical but still enigmatic pathogenic pathway leading to pulmonary insufficiency in CF patients. Laurent Pharmaceuticals was founded in 2012 and is headquartered in Montréal, Quebec.

Total Funding Amount:

$10M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Montréal, Quebec, Canada

Founded Date:

2012-01-01

Contact Email:

info(AT)laurentpharma.com

Founders:

Patrick Colin

Number of Employees:

1-10

Last Funding Date:

2019-12-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai